CTRI/2024/03/064618
Not yet recruiting
Phase 2
Comparison of Myocardial protection between Adenosine-Lignocaine-Magnesium Polarising Cardioplegia and St. Thomas Cardioplegia in Routine Elective Adult Cardiac Surgery: Randomised Double Blinded Controlled Trial. - NI
Head of the Department Department of Cardiac Anesthesiology0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Head of the Department Department of Cardiac Anesthesiology
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •patients undergoing open heart surgery under Cardiopulmonary bypass
Exclusion Criteria
- •Patient refusal
- •Patients below age of 18 years
- •Congenital Cyanotic heart disease
- •Emergency surgery
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Comparative analysis of two solutions for miocardial protection in the correction of congenital cardiopathies.Children with acyanogenic congenital heart defects operated for total correctionTraced problems - Myocardial damageSpecific descriptors - Interventricular communication, Atrioventricular communication, Right ventricle with double outlet, Tetralogy of Fallot, Myocardial protection.Q21.0Q21.2Q20.1Q21.3C14.280H02.403.670C14.280.647C14.280.671RBR-9wqbx9Hospital do Coração de Messejana Dr. Carlos Alberto Studart Gomes
Completed
Phase 3
Myocardial protection in cardiac surgeryCardiopulmonary bypass.Nonrheumatic mitral valve disorder, unspecifiedI34.9IRCT20191024045227N1Iran University of Medical Sciences74
Active, not recruiting
Not Applicable
A comparison of Myocardial Protection Using Preconditioning with Sevoflurane Against High Thoracic Epidural Analgesia for CABG SurgeryEUCTR2005-004398-76-GBGolden Jubilee National Hospital150
Completed
Phase 2
The effect of Adenosine on Myocardial Protection in Intermittent warm blood Cardioplegia: a randomized placebo-controlled trialNL-OMON42535Amphia Ziekenhuis100
Active, not recruiting
Phase 1
Adenosine as an adjunct to standaard blood cardioplegiaPost-operative cardiac damage in patients scheduled for minimal invasive, port-access operationsTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2015-001923-22-NLAmphia Ziekenhuis100